115 related articles for article (PubMed ID: 28126663)
1. miRNases: Novel peptide-oligonucleotide bioconjugates that silence miR-21 in lymphosarcoma cells.
Patutina OA; Bichenkova EV; Miroshnichenko SK; Mironova NL; Trivoluzzi LT; Burusco KK; Bryce RA; Vlassov VV; Zenkova MA
Biomaterials; 2017 Apr; 122():163-178. PubMed ID: 28126663
[TBL] [Abstract][Full Text] [Related]
2. Bulge-Forming miRNases Cleave Oncogenic miRNAs at the Central Loop Region in a Sequence-Specific Manner.
Patutina O; Chiglintseva D; Amirloo B; Clarke D; Gaponova S; Vlassov V; Bichenkova E; Zenkova M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743015
[TBL] [Abstract][Full Text] [Related]
3. Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model.
Patutina OA; Miroshnichenko SK; Mironova NL; Sen'kova AV; Bichenkova EV; Clarke DJ; Vlassov VV; Zenkova MA
Front Pharmacol; 2019; 10():879. PubMed ID: 31456683
[TBL] [Abstract][Full Text] [Related]
4. Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance.
Patutina O; Chiglintseva D; Bichenkova E; Gaponova S; Mironova N; Vlassov V; Zenkova M
Molecules; 2020 May; 25(10):. PubMed ID: 32466298
[TBL] [Abstract][Full Text] [Related]
5. Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H.
Patutina OA; Bazhenov MA; Miroshnichenko SK; Mironova NL; Pyshnyi DV; Vlassov VV; Zenkova MA
Sci Rep; 2018 Oct; 8(1):14990. PubMed ID: 30302012
[TBL] [Abstract][Full Text] [Related]
6. Site-Selective Artificial Ribonucleases: Renaissance of Oligonucleotide Conjugates for Irreversible Cleavage of RNA Sequences.
Staroseletz Y; Gaponova S; Patutina O; Bichenkova E; Amirloo B; Heyman T; Chiglintseva D; Zenkova M
Molecules; 2021 Mar; 26(6):. PubMed ID: 33808835
[TBL] [Abstract][Full Text] [Related]
7. Misprocessing and functional arrest of microRNAs by miR-Pirate: roles of miR-378 and miR-17.
Deng Z; Yang X; Fang L; Rutnam ZJ; Yang BB
Biochem J; 2013 Mar; 450(2):375-86. PubMed ID: 23210454
[TBL] [Abstract][Full Text] [Related]
8. Engineering supramolecular dynamics of self-assembly and turnover of oncogenic microRNAs to drive their synergistic destruction in tumor models.
Chiglintseva D; Clarke DJ; Sen'kova A; Heyman T; Miroshnichenko S; Shan F; Vlassov V; Zenkova M; Patutina O; Bichenkova E
Biomaterials; 2024 Sep; 309():122604. PubMed ID: 38733658
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics.
Miroshnichenko S; Patutina O
Front Pharmacol; 2019; 10():488. PubMed ID: 31156429
[TBL] [Abstract][Full Text] [Related]
10. PNA-based artificial nucleases as antisense and anti-miRNA oligonucleotide agents.
Gaglione M; Milano G; Chambery A; Moggio L; Romanelli A; Messere A
Mol Biosyst; 2011 Aug; 7(8):2490-9. PubMed ID: 21623442
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of MicroRNAs in Gastric Lymphomagenesis Induced in the d3Tx Mouse Model of
Floch P; Capdevielle C; Staedel C; Izotte J; Sifré E; Laur AM; Giese A; Korolik V; Dubus P; Mégraud F; Lehours P
Front Cell Infect Microbiol; 2017; 7():185. PubMed ID: 28560185
[No Abstract] [Full Text] [Related]
12. Antitumour Activity of the Ribonuclease Binase from
Mohamed ISE; Sen'kova AV; Nadyrova AI; Savin IA; Markov AV; Mitkevich VA; Makarov AA; Ilinskaya ON; Mironova NL; Zenkova MA
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33147876
[TBL] [Abstract][Full Text] [Related]
13. Control of oncogenic miRNA function by light-activated miRNA antagomirs.
Connelly CM; Deiters A
Methods Mol Biol; 2014; 1165():99-114. PubMed ID: 24839022
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
15. Making oligonucleotide conjugates and breaking oligonucleotides.
Milton S; Murtola M; Sandbrink J; Yeheskiely E; Strömberg R
Nucleic Acids Symp Ser (Oxf); 2007; (51):61. PubMed ID: 18029586
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
17. Silencing of microRNAs in vivo with 'antagomirs'.
Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
[TBL] [Abstract][Full Text] [Related]
18. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
19. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.
Cheng AM; Byrom MW; Shelton J; Ford LP
Nucleic Acids Res; 2005; 33(4):1290-7. PubMed ID: 15741182
[TBL] [Abstract][Full Text] [Related]
20. Strict conformational demands of RNA cleavage in bulge-loops created by peptidyl-oligonucleotide conjugates.
Staroseletz Y; Amirloo B; Williams A; Lomzov A; Burusco KK; Clarke DJ; Brown T; Zenkova MA; Bichenkova EV
Nucleic Acids Res; 2020 Nov; 48(19):10662-10679. PubMed ID: 33010175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
